New Modality Support, or NMS in short, is a project coordinated by GU Ventures and based at GoCo Health Innovation City in Mölndal. The aim of the project is to facilitate scaling up individual research projects in the ATMP/Therapeutic Oligonucleotides arena. It supports business development and investments throughout the process, from research results and company formation to commercialization.
Participating partners
NMS is a cooperative project founded by CCRM Nordic, OligoNova, Sahlgrenska Academy at the University of Gothenburg, GU Ventures and the Sahlgrenska University Hospital.
Do you want to know more about NMS?
Please visit our website to learn more.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Göteborg, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://newmodalitysupport.se/
- Keywords
- Forskning inom bioteknik.
- HQ
- Göteborg
New Modality Support Questions
New Modality Support's website is https://newmodalitysupport.se/
New Modality Support's LinkedIn profile is https://se.linkedin.com/company/new-modality-support
New Modality Support has
2 employees.
View email and phone details for 2
employees at New Modality Support.
New Modality Support's industry is
Biotechnology Research
New Modality Support's top competitors are
Novo Nordisk,
Aiomica A.s.,
Mötesplats Steneby,
Goh Ventures,
Ccrm Nordic,
Trillium Solutions,
Gu Ventures,
Energo Network,
Oligonova Hub,
Mölnlycke Health Care.
New Modality Support's categories are Biotechnology Research
New Modality Support's founding year is 2024
